Canada · Health Canada Drug Product Database

ALPHALIGO

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 53833
DIN: 02233817
Form: Tablet
Company as listed by source: CLINIQUE LAFONTAINE INC, DIVISION LES IMPORTATIONS ORTHO
Source status: Cancelled Post Market (2008-08-07)
Source last updated: 2025-03-22

Source-listed ingredients

PHOSPHORUS (SODIUM PHOSPHATE) — 125 MG
MAGNESIUM (MAGNESIUM PROTEINATE, MAGNESIUM OXIDE) — 119 MG
POTASSIUM (POTASSIUM CHLORIDE, POTASSIUM PROTEINATE) — 112.5 MG
MANGANESE (MANGANESE CHLORIDE, MANGANESE PROTEINATE) — 4.5 MG
COBALT (VITAMIN B12) — 10 MCG

These values do not establish equivalence or a dose recommendation.

Packages

Source and coverage

Open Health Canada Drug Product Database →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse Canada records →